129 related articles for article (PubMed ID: 15613721)
21. Segmentation of Retinal Layers in Sjögren-Larsson Syndrome.
Jack LS; Benson C; Sadiq MA; Rizzo WB; Margalit E
Ophthalmology; 2015 Aug; 122(8):1730-2. PubMed ID: 25784589
[No Abstract] [Full Text] [Related]
22. A novel homozygous missense mutation in the fatty aldehyde dehydrogenase gene causes Sjögren-Larsson syndrome.
Nakano H; Akasaka E; Rokunohe D; Yokoyama S; Toyomaki Y; Umegaki N; Mitsuhashi Y; Sawamura D
J Dermatol Sci; 2008 Nov; 52(2):136-8. PubMed ID: 18684595
[No Abstract] [Full Text] [Related]
23. Microsomal fatty aldehyde dehydrogenase catalyzes the oxidation of aliphatic aldehyde derived from ether glycerolipid catabolism: implications for Sjögren-Larsson syndrome.
Rizzo WB; Heinz E; Simon M; Craft DA
Biochim Biophys Acta; 2000 Dec; 1535(1):1-9. PubMed ID: 11113626
[TBL] [Abstract][Full Text] [Related]
24. Optical coherence tomography aspect of crystalline macular dystrophy in Sjögren-Larsson syndrome.
Bhallil S; Chraibi F; Andalloussi IB; Tahri H
Int Ophthalmol; 2012 Oct; 32(5):495-8. PubMed ID: 22932746
[TBL] [Abstract][Full Text] [Related]
25. Sjögren-Larsson syndrome: technique and timing of prenatal diagnosis.
Tabsh K; Rizzo WB; Holbrook K; Theroux N
Obstet Gynecol; 1993 Oct; 82(4 Pt 2 Suppl):700-3. PubMed ID: 8378019
[TBL] [Abstract][Full Text] [Related]
26. 5-Lipoxygenase inhibition: a new treatment strategy for Sjögren-Larsson syndrome.
Willemsen MA; Rotteveel JJ; Steijlen PM; Heerschap A; Mayatepek E
Neuropediatrics; 2000 Feb; 31(1):1-3. PubMed ID: 10774987
[TBL] [Abstract][Full Text] [Related]
27. Sjögren-Larsson syndrome: report of monozygote twins and a case with a novel mutation.
Yiş U; Terrinoni A
Turk J Pediatr; 2012; 54(1):64-6. PubMed ID: 22397046
[TBL] [Abstract][Full Text] [Related]
28. Sjögren-Larsson syndrome: biochemical defects and follow up in three cases.
Auada MP; Taube MB; Collares EF; Tanaka AM; Cintra ML
Eur J Dermatol; 2002; 12(3):263-6. PubMed ID: 11978568
[TBL] [Abstract][Full Text] [Related]
29. Depletion of alcohol (hexanol) dehydrogenase activity in the epidermis and jejunal mucosa in Sjögren-Larsson syndrome.
Judge MR; Lake BD; Smith VV; Besley GT; Harper JI
J Invest Dermatol; 1990 Dec; 95(6):632-4. PubMed ID: 2250105
[TBL] [Abstract][Full Text] [Related]
30. Sjögren-Larsson syndrome in clinical practice.
Fuijkschot J; Theelen T; Seyger MM; van der Graaf M; de Groot IJ; Wevers RA; Wanders RJ; Waterham HR; Willemsen MA
J Inherit Metab Dis; 2012 Nov; 35(6):955-62. PubMed ID: 22833178
[TBL] [Abstract][Full Text] [Related]
31. Identification of Homozygous Likely Pathogenic Variant of ALDH3A2 in a Korean Boy with Sjögren-Larsson Syndrome.
Kim JY; Kim SH; Park MJ; Kim SH; Cho WH; Choi J; Ki CS; You SJ
Ann Lab Med; 2018 Jan; 38(1):80-82. PubMed ID: 29071827
[No Abstract] [Full Text] [Related]
32. Sjögren-Larsson syndrome: early diagnosis, dietary management and biochemical studies in two cases.
Taube B; Billeaud C; Labrèze C; Entressangles B; Fontan D; Taïeb A
Dermatology; 1999; 198(4):340-5. PubMed ID: 10449931
[TBL] [Abstract][Full Text] [Related]
33. Bezafibrate induces FALDH in human fibroblasts; implications for Sjögren-Larsson syndrome.
Gloerich J; Ijlst L; Wanders RJ; Ferdinandusse S
Mol Genet Metab; 2006; 89(1-2):111-5. PubMed ID: 16837225
[TBL] [Abstract][Full Text] [Related]
34. Sjögren-Larsson syndrome caused by novel mutations in ALDH3A2 gene.
Le NTA; Nguyen HLT; Trinh BN; Dang HH
Int J Dermatol; 2023 Jan; 62(1):e2-e4. PubMed ID: 36030534
[No Abstract] [Full Text] [Related]
35. Diagnosing Sjögren-Larsson syndrome in a 7-year-old Moroccan boy.
Bernardini ML; Cangiotti AM; Zamponi N; Porfiri L; Cinti S; Offidani A
J Cutan Pathol; 2007 Mar; 34(3):270-5. PubMed ID: 17302612
[TBL] [Abstract][Full Text] [Related]
36. Novel ALDH3A2 heterozygous mutations in a Japanese family with Sjögren-Larsson syndrome.
Sakai K; Akiyama M; Watanabe T; Sanayama K; Sugita K; Takahashi M; Suehiro K; Yorifuji K; Shibaki A; Shimizu H
J Invest Dermatol; 2006 Nov; 126(11):2545-7. PubMed ID: 16794583
[No Abstract] [Full Text] [Related]
37. Sjögren-Larsson syndrome is caused by mutations in the fatty aldehyde dehydrogenase gene.
De Laurenzi V; Rogers GR; Hamrock DJ; Marekov LN; Steinert PM; Compton JG; Markova N; Rizzo WB
Nat Genet; 1996 Jan; 12(1):52-7. PubMed ID: 8528251
[TBL] [Abstract][Full Text] [Related]
38. Sjögren-Larsson syndrome in Brazil is caused by a common c.1108-1G-->C splice-site mutation in the ALDH3A2 gene.
Auada MP; Puzzi MB; Cintra ML; Steiner CE; Alexandrino F; Sartorato EL; Aguiar TS; Azulay RD; Carney G; Rizzo WB
Br J Dermatol; 2006 Apr; 154(4):770-3. PubMed ID: 16536828
[No Abstract] [Full Text] [Related]
39. Phytol/Phytanic acid and insulin resistance: potential role of phytanic acid proven by docking simulation and modulation of biochemical alterations.
Elmazar MM; El-Abhar HS; Schaalan MF; Farag NA
PLoS One; 2013; 8(1):e45638. PubMed ID: 23300941
[TBL] [Abstract][Full Text] [Related]
40. What syndrome is this? Sjögren-Larsson syndrome.
Carney S; Mallory SB; Kibarian MA
Pediatr Dermatol; 1993 Sep; 10(3):289-91. PubMed ID: 8415311
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
